Validation of an instrument for the documentation of clinical pharmacists' interventions

B Allenet, P Bedouch, FX Rose, L Escofier… - Pharmacy World and …, 2006 - Springer
Objective To validate an instrument for documentation of clinical pharmacy interventions in
French speaking hospitals in France and outside of France. Method A panel of 12 French …

Tools for assessing potential significance of pharmacist interventions: a systematic review

TH Vo, B Charpiat, C Catoire, M Juste, R Roubille… - Drug safety, 2016 - Springer
Introduction Assessing the significance of pharmacist interventions (PIs) is essential to
demonstrate the added value of pharmacists. Methods and tools for assessing the potential …

Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study

P Bedouch, B Charpiat, O Conort… - Annals of …, 2008 - journals.sagepub.com
Background: The development of clinical pharmacy activities in most European countries is
underway; however, data on these activities are still poorly reported. Multicenter studies are …

CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists' interventions

HT Vo, B Charpiat, S Chanoine, M Juste… - European Journal of …, 2021 - ejhp.bmj.com
Objectives Clinical pharmacists' interventions (PIs) are an important element in ensuring
good pharmaceutical care. We aimed to develop and validate a comprehensive …

Epidural, intrathecal pharmacokinetics, and intrathecal bioavailability of ropivacaine

FX Rose, JP Estebe, M Ratajczak, E Wodey… - Anesthesia & …, 2007 - journals.lww.com
BACKGROUND: Ropivacaine is used by the epidural route for postoperative pain
management with various neuraxial techniques. Given the widespread use of these …

Facteurs à prendre en considération pour la gestion des interactions médicamenteuses en pratique clinique

B Charpiat, B Allenet, R Roubille, L Escofier… - La Presse Médicale, 2008 - Elsevier
Points essentiels Il existe de très nombreuses interactions médicamenteuses et il est
impossible de toutes les retenir. Leur détection et la prévention des effets indésirables …

[PDF][PDF] Electronic Supplementary Material 4. Process of validation of tools in 133 identified studies

TH VO, B CHARPIAT, C CATOIRE, M JUSTE… - researchgate.net
Note:" IN"= individual-based rating." GR"= group-based rating." ND"= non-determined." _"=
Not reported."*"= Distinct tool." ME"= medication error." PI"= pharmacist intervention. 1, 2 …

[PDF][PDF] Electronic Supplementary Material 3. Content and Structure of Tools in 133 identified studies

TH VO, B CHARPIAT, C CATOIRE, M JUSTE… - researchgate.net
➢ Approach of assessment: Approach 3 is the estimation of potential significance of a PI.
The approach 3A–prediction of the potential consequences of DRPs in absence of a PI; …

[PDF][PDF] Electronic Supplementary Material 5. Indicators used in existing tools for assessment of potential significance of PIs

TH VO, B CHARPIAT, C CATOIRE, M JUSTE… - researchgate.net
Clinical Safety [28, 75, 134, 140, 158], adverse health consequence [48], adverse effect [50,
77, 87, 101, 103], ADE [3, 102, 106], harmful effect [21], ADR [66, 89, 123], detrimental effect …

Electronic Supplementary Material 2. Criteria of quality of a tool for assessing significance of PIs

TH VO, B CHARPIAT, C CATOIRE, M JUSTE… - researchgate.net
Electronic Supplementary Material 2. Criteria of quality of a tool for assessing significance of
PIs Journal: Drug Safety Arti Page 1 Electronic Supplementary Material 2. Criteria of quality of …